Search Results

. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance

. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance

Take your idea, platform, or early data and turn it into a strategic roadmap with clear decisions, timelines How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence Decisions, Not More Data Prioritize assays based on project phase and decision points Map go/no-go logic that guides program momentum confidence Trusted by Biotech Innovators Before working with Yamina, we were navigating challenging decisions You walk away with a decision-ready roadmap, improved CRO output, and faster movement through your discovery

Biotech Leaders & Scientists Actionable Data Insights: Translate complex GPCR pharmacology into clear decisions to remove roadblocks, enhance execution, and generate actionable scientific data, driving confident decisions This partnership prevents bottlenecks and optimizes resource allocation, ensuring every strategic decision This ensures robust, defensible decisions that de-risk your program from early discovery to regulatory I’ve worked with her on several discovery programs; in fragmented programs she bought clarity and decision

Bridge theory to practical drug development decisions? Terry's Corner helps you make better decisions through better pharmacology.

Launching July 1, Terry’s Corner gives you the clarity and confidence to make better decisions—starting Launching July 1, Terry’s Corner gives you the clarity and confidence to make better decisions—starting

Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade Translate project strategy into clear decision-driving assays Eliminate “nice to have” tests that stall I bring structure, decision frameworks, and momentum so your team stays on track. I’ve worked with her on several discovery programs; in fragmented programs, she brought clarity and decision

Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug

Precision in early decisions determines whether your molecule moves forward or stalls. complexity using functional assay strategies Identify allosteric modulators before they derail downstream decisions

“The data looks fine, but it doesn’t help us make decisions.” and reduce delays • Align teams across roles—from assay execution to client updates Data Turns Into Decisions—Not science into clear deliverables • Define program objectives and guide assay plans that support partner decisions

Apply pharmacology to selectivity, ADME, and strategic decision-making. An experienced drug hunter? Apply pharmacology to selectivity, ADME, and strategic decision-making. An experienced drug hunter?

They’re stalling because of slow decisions, misapplied models, and buried priorities.

In modern discovery programs, that’s a decisive advantage (or a hidden liability) in candidate selection

It shaped how we design experiments, make decisions, and lead teams. In this week’s Dr.

corner launches Published on July 4, 2025 Category GPCR Weekly News Stronger pharmacology drives smarter decisions

molecular pharmacology with real-world design strategy, giving discovery teams the tools to make smarter decisions

Translate early data into better decisions. This is more than another course.

Decision-Making: Saying Yes to the Unorthodox Path Serafini’s journey defied traditional checklists. His approach to decision-making is pragmatic: follow impact, not orthodoxy. The decision to stay on as a postdoc in the same lab as his PhD — with Dr.

I want to connect more trainees with diverse career resources to support professional decision-making opportunities of my peers, in combination with my own scientific endeavors, will inform my future career decisions

Family First, Always The decision to shift from academia to industry wasn’t driven by disillusionment—it This pragmatic decision led him to high-throughput screening at DuPont, proving that scientific ambition

for Biotech Growth Operational System Design (OS) Cross-functional Team Alignment Scaling Protocols & Decision

Science Journey and Postdoc Decision Mike discussed his journey into science and his decision to pursue Career Trajectory and Faculty Position Yamina and Mike discussed Mike's career trajectory and his decision

Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

Decision-Making: From Researcher to Scientific Leader Maria’s story is one of trusting her instincts I wasn’t sure at first, but I realized I could do this too.” — Maria Majellaro Her decisions, often made

Get Premium for Full Access Latest Issues How System-Level GPCR Insights Strengthen Every Discovery Decision

Network with leading professionals and decision-makers in the industry.

chemistry to pioneering peptide–fluorophore conjugates for the GLP-1 receptor, JB breaks down the strategic decisions

It shaped how we design experiments, make decisions, and lead teams. In this week’s Dr. Translate early data into better decisions. This is more than another course. Precision in early decisions determines whether your molecule moves forward or stalls. complexity using functional assay strategies Identify allosteric modulators before they derail downstream decisions molecular pharmacology with real-world design strategy, giving discovery teams the tools to make smarter decisions

De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before

Results-Driven Every tool and content block is built to help you make a decision or move forward. ✔ GPCR-specific